TransMedics Group, Inc. (TMDX)
84.22
+1.98
(+2.41%)
USD |
NASDAQ |
Sep 02, 16:00
84.40
+0.18
(+0.21%)
After-Hours: 18:50
TransMedics Group Research and Development Expense (TTM) : 92.47M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.47M |
| March 31, 2026 | 76.77M |
| December 31, 2025 | 69.06M |
| September 30, 2025 | 64.82M |
| June 30, 2025 | 63.82M |
| March 31, 2025 | 61.75M |
| December 31, 2024 | 55.97M |
| September 30, 2024 | 50.26M |
| June 30, 2024 | 47.13M |
| March 31, 2024 | 41.56M |
| December 31, 2023 | 36.06M |
| September 30, 2023 | 31.05M |
| June 30, 2023 | 26.73M |
| March 31, 2023 | 25.15M |
| December 31, 2022 | 26.81M |
| September 30, 2022 | 27.37M |
| June 30, 2022 | 25.72M |
| March 31, 2022 | 25.31M |
| Date | Value |
|---|---|
| December 31, 2021 | 22.30M |
| September 30, 2021 | 20.54M |
| June 30, 2021 | 19.53M |
| March 31, 2021 | 17.14M |
| December 31, 2020 | 18.83M |
| September 30, 2020 | 20.54M |
| June 30, 2020 | 21.33M |
| March 31, 2020 | 22.21M |
| December 31, 2019 | 19.87M |
| September 30, 2019 | 17.09M |
| June 30, 2019 | 15.43M |
| March 31, 2019 | 14.07M |
| December 31, 2018 | 13.66M |
| September 30, 2018 | 13.57M |
| June 30, 2018 | 13.70M |
| March 31, 2018 | 14.46M |
| December 31, 2017 | 14.96M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alphatec Holdings, Inc. | 76.69M |
| Artivion, Inc. | 35.10M |
| Insulet Corp. | 345.90M |
| Teleflex, Inc. | 195.47M |
| Globus Medical, Inc. | 147.06M |